The CRDG UK has launched ‘Going for Growth: How to Make the UK the Global Leader in Cannabinoid R&D’ Stand-out recommendations to realise the UK’s opportunity to grow life science investment 👇 - Transfer the licensing for medical cannabis R&D away from the Home Office - Allow exemptions for cannabinoid research - Attract investment by fostering industry and academic partnerships across the sector “This report details why our industry should work together and how larger scale investment will accelerate cannabinoid drug development to allow the UK to lead the scientific pathway to improve patient access.” Mikael Sodergren, Chief Medical Officer at Curaleaf International, commenting on the group’s findings and recommendations as a founding member. Download the full report here 👉 https://lnkd.in/e3ydXAxd
Curaleaf International
Biotechnology Research
London, England 10,473 followers
Advancing the Science of Nature.
About us
Curaleaf International is unlocking the transformative power of medical cannabis by empowering patients and healthcare professionals with knowledge and access to cannabis-based therapies. It is a market leader in the UK and Europe, focused on quality and delivering safe and effective care for all.
- Website
-
https://www.curaleafinternational.com
External link for Curaleaf International
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- London, England
- Type
- Public Company
- Founded
- 2018
Locations
-
Primary
Gilmoora House, 57-61 Mortimer Street
London, England W1W 8HS, GB
Employees at Curaleaf International
Updates
-
Amongst world-leading experts in the #cannabis research field, Research Director Simon Erridge presented the clinical outcomes of medical cannabis for chronic cancer pain at #ICRS2024 this week. Together with Mikael Sodergren they showcased proprietary data from the UK Medical Cannabis Registry gathered via Curaleaf Clinic. Commenting on the symposium, they agreed: “It has been fantastic to see the growing range of clinical studies that complement the pre-clinical science that is always on display at this leading international conference."
-
Curaleaf International are looking forward to the 34th Annual INTERNATIONAL CANNABINOID RESEARCH SOCIETY (ICRS) Symposium, taking place from June 30 – July 5, 2024, in #Salamanca, #Spain. Dr Simon Erridge, Research Director at Curaleaf Clinic, and Dr Mikael Sodergren, Chief Medical Officer at Curaleaf International, will be attending this event for the fourth consecutive year. https://lnkd.in/e6V-kdTB
-
Curaleaf International at Cannabis Europa: key takeaways from the industry event. #CannabisEuropa #CuraleafInternational #CannabisIndustry #MedicalCannabis #GlobalTrade #InnovationInCannabis
-
Honoured to have received 4 awards this evening in recognition of the outstanding leadership, achievements and contributions the team deliver for this industry each day. 🏆European Cannabis Company of the Year 🏆 Business Leader of the Year Boris Jordan Curaleaf 🏆Cannabis Clinic of the Year Curaleaf Clinic 🏆Cultivator of the Year #medicalcannabis #grateful #congratulations #celebrate
-
Curaleaf International at Cannabis Europa: we recap the afternoon sessions of day one. #CannabisEuropa #CuraleafInternational #GlobalCannabisTrade #IndustryInsights #InnovationInCannabis
Cannabis Europa 2024: A look at the future dynamics of global cannabis trade
Curaleaf International on LinkedIn
-
Cannabis Europa 2024: Key takeaways from the first morning’s sessions. The team at Curaleaf International is once again in attendance at Cannabis Europa, the largest international cannabis conference, held in the heart of London. #CannabisEuropa #CuraleafInternational #CannabisIndustry #MedicalCannabis
Cannabis Europa 2024: Key takeaways from the first morning’s sessions
Curaleaf International on LinkedIn
-
ICYMI: Juan Pablo, Head of Curaleaf International, featured twice in Benzinga Cannabis last week with Nicolas J Rodriguez. Juan speaks openly about: - Industry challenges - Market potential - Strategic expansion - Growing the Curaleaf brand Specifically on Germany, he commented, “The changes in regulation, such as the recent introduction of Pillar One, have already doubled the patient base, indicating a strong potential for further growth as more regulatory improvements are implemented." Here's the coverage: https://lnkd.in/eU2R2wqs #CannabisIndustry #FutureOfCannabis #CuraleafInternational
Curaleaf International Is Beating Illicit Cannabis Prices In UK And Germany - What's Next For EU Expansion? - Curaleaf Holdings (OTC:CURLF)
benzinga.com
-
🌟 We are pleased to announce that we have been shortlisted for FIVE Business of Cannabis awards Business of Cannabis | Europe! 🌟 In recognition of the hard work, dedication, and innovation our team brings to the cannabis industry every day, here are the nominations: - Boris Jordan, Business Leader of the Year. - Simon Erridge, Industry Rising Star. - Curaleaf Clinic, Cannabis Clinic of the Year. - Curaleaf International, Cultivation of the Year. - Curaleaf International, European Cannabis Company of the Year. Congratulations to all those shortlisted! We are excited to celebrate the achievements and advancements within our industry.
Business of Cannabis Awards 🏆 We are thrilled to announce the nominees for the European Cannabis Company of the Year award! This prestigious award recognises outstanding achievements and contributions made by cannabis companies operating within the European market. And the shortlisted nominees are... 🥁 Cansativa Group Curaleaf International Cantourage STENOCARE A/S Agropharm Projects Blossom DEMECAN We deeply appreciate all the nominees for their outstanding efforts and contributions to the European cannabis industry. Your commitment and accomplishments are immensely valued and continue to drive innovation and growth in the field. Join us at the awards party, get your ticket now 🎟️👇https://lnkd.in/eKB_ixm3
-
One week to go! We are gearing up for Cannabis Europa, the conference that brings together the brightest minds and most influential voices in the cannabis industry. As headline partner, our team will be well-represented with four outstanding speakers: - Boris Jordan, Chief Executive, Curaleaf - Juan Pablo M. , Head of Curaleaf International - Thomas Schatton, Managing Director Four 20 Pharma GmbH - Jonathan Hodgson, Managing Director UK and Nordics, Curaleaf International This is an opportunity to engage with industry leaders, share insights, and discuss the future of cannabis in Europe and beyond. We look forward to connecting, learning, and contributing to the conversation. Check out the full agenda and join us at #CE2024 https://lnkd.in/gSpSv4JU #CannabisIndustry #FutureOfCannabis #Networking #IndustryLeaders
1 WEEK TO GO 🎉 Team Cannabis Europa are busy putting the final touches together for one of the most exciting events of the year! VIP tickets are sold out, 4-for-3 availability is low... If you haven't already secured your seat, we highly encourage you to get yours now. Roll on next week and can't wait to see you all there! 🎟️ https://lnkd.in/eQgK2Mk5 #CE2024